Strengthening regulatory framework, India to join global quality scheme

14 June 2023
india_mumbai_large

India is to join an international system - the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme (PIC/S) - that fosters cooperation between countries and regulatory authorities on good manufacturing practices (GMPs) in order to improve the quality of its medical products.

A government official confirmed that as a member of the PIC/S, India is poised to enhance the quality of its medical products and improve market access. A number of incidents, including the tragic death of several children in Gambia related to toxic Indian cough syrups, have led to this decision, as well as difficulties in accessing the market for Indian medical products in quality-conscious regions such as the United Arab Emirates (UAE) and the Gulf Cooperation Council.

By joining the PIC/S, India will be able to adopt global standards. It would help pave the way for greater international cooperation and regulations, the official added.
PIC/S requires Indian industries, particularly micro, small, and medium enterprises, to adhere to international standards, specifically addressing GMPs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical